Structure Therapeutics Oral GLP-1 Obesity Drug Achieves ‘Injectable-Like Efficacy’ in Phase 2 Test
Construction Therapeutics’ aleniglipron, a once-daily oral GLP-1 drug, led to a mean 16% weight reduction measured at 44 weeks. Primarily ...
Tag: Therapeutics
Is Aldeyra Therapeutics waving red flags with consequences?
Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Road, and ...
Candid Therapeutics Strikes Up Merger With Rallybio to Advance Its Autoimmune Drug Pipeline
Together with the reverse merger, Candid Therapeutics introduced $505 million in non-public financing to help its pipeline of T cell ...
Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions
Atrium spun out of Avidity Biosciences, which Novartis acquired in a $12 billion deal. The Atrium pipeline is led by ...
New technique synthesizes non-natural amino acids for advanced peptide therapeutics
Ozempic has been making headlines for its outstanding success in treating weight problems and diabetes. But it is only one ...
PTC Therapeutics Ends Bid to Seek FDA Approval for Rare Muscle Disease Drug
For greater than a decade, PTC Therapeutics has been going backwards and forwards with the FDA to discover a path ...
Tahoe Therapeutics generates the largest single-cell atlas ever using INTEGRA Biosciences automated pipetting technologies
Tahoe Therapeutics – a biotech start-up based mostly in San Francisco, California – is creating the most important ever atlas ...
BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition
Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus ...
TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board
TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today ...
Summit Therapeutics hits possible snag on lung cancer drug seen as blockbuster
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!